Stephanie Fradette

Company: Biogen Idec
Job title: Senior Director - Medical & Clinical Development
Seminars:
Showcasing Clinical Findings for Toferson: Disease-Modifying Capabilities Targeting SOD1 Genetic Mutation 8:30 am
• Explaining ongoing clinical strategy in extended phase 3 clinical trials • Outlining lessons learnt regarding clinical endpoints from interactions with regulatory authorities • What is the future for therapies targeting familial ALS seeking approval?Read more
day: Day One AM